Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Assessment of the Association between Isocitrate Dehydrogenase 1 Mutation and Mortality Risk of Glioblastoma Patients.

Molecular neurobiology - 1 Apr 2016

Dai Yuting, Ning Xianbin, Han Guoqian, Li Wei

Abstract excerpt

Previous studies showed that isocitrate dehydrogenase 1 (IDH1) mutation might be a prognostic biomarker of prognosis in glioblastoma (GBM) patients, but the outcomes were various. A meta-analysis of published studies was carried out to reach a reliable assessment of the association between IDH1 mutation and mortality of GBM patients. Relative risks (RRs) with 95% confidence intervals (95%CIs) were pooled using...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asia
Share to Brain Neoplasms
Share to Europe

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioblastoma

Share to Isocitrate Dehydrogenase

Share to Neoplasm Proteins

Share to North America

Source

Identifiers

PMID: 25650121
DOI: 10.1007/s12035-015-9104-7

Genes

IDH1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Assessment of the Association between Isocitrate Dehydrogenase 1 Mutation and Mortality Risk of Glioblastoma Patients.PMID 25650121Read ↗

IDH1 mutation is associated with improved overall survival in patients with glioblastoma: a meta-analysis.Semantic proximity Read ↗

Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas.Semantic proximity Read ↗

[Isocitrate dehydrogenase type I mutation as a prognostic factor in glioblastoma and a literature review].Semantic proximity Read ↗

Prognostic significance of IDH 1 mutation in patients with glioblastoma multiforme.Semantic proximity Read ↗

IDH1/IDH2 mutations define the prognosis and molecular profiles of patients with gliomas: a meta-analysis.Semantic proximity Read ↗

Concordance analysis and diagnostic test accuracy review of IDH1 immunohistochemistry in glioblastoma.Semantic proximity Read ↗

Prognostic significance of IDH mutation in adult low-grade gliomas: a meta-analysis.Semantic proximity Read ↗

Prognostic role of IDH mutations in gliomas: a meta-analysis of 55 observational studies.Semantic proximity Read ↗

Isocitrate Dehydrogenase-1 Mutations as Prognostic Biomarker in Glioblastoma Multiforme Patients in West BohemiaSemantic proximity Read ↗

A novel literature-based approach to identify genetic and molecular predictors of survival in glioblastoma multiforme: Analysis of 14,678 patients using systematic review and meta-analytical tools.Semantic proximity Read ↗

Isocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild type.Semantic proximity Read ↗

Genetics and Epigenetics of Glioblastoma: Applications and Overall Incidence of IDH1 MutationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.